Cargando…
Atypical PKC: therapeutic target for Alzheimer’s?
Autores principales: | Farese, Robert V., Sajan, Mini P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339803/ https://www.ncbi.nlm.nih.gov/pubmed/30573704 http://dx.doi.org/10.18632/aging.101730 |
Ejemplares similares
-
Hepatic Atypical Protein Kinase C: An Inherited Survival-Longevity Gene that Now Fuels Insulin-Resistant Syndromes of Obesity, the Metabolic Syndrome and Type 2 Diabetes Mellitus
por: Farese, Robert V., et al.
Publicado: (2014) -
Contraction stimulates muscle glucose uptake independent of atypical PKC
por: Yu, Haiyan, et al.
Publicado: (2015) -
Akt-Dependent Phosphorylation of Hepatic FoxO1 Is Compartmentalized on a WD40/ProF Scaffold and Is Selectively Inhibited by aPKC in Early Phases of Diet-Induced Obesity
por: Sajan, Mini P., et al.
Publicado: (2014) -
Impairment of insulin-stimulated glucose transport and ERK activation by adipocyte-specific knockout of PKC-λ produces a phenotype characterized by diminished adiposity and enhanced insulin suppression of hepatic gluconeogenesis
por: Sajan, Mini P, et al.
Publicado: (2014) -
Roles of hepatic atypical protein kinase C hyperactivity and hyperinsulinemia in insulin‐resistant forms of obesity and type 2 diabetes mellitus
por: Sajan, Mini P., et al.
Publicado: (2021)